基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Frist Thomas F III, 董事. Director active across 3 companies, notably Verisign Inc/ca. Cumulatively, 12 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €19k. History available since 19 July 2021. The latest transaction was filed on 28 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
FRIST THOMAS F III is Administrateur at HCA Healthcare, Inc., Verisign Inc/ca and Science Applications International Corp. He has 12 filings in total, and across the 12 sampled filings the reported volume is EUR 18700 of purchases and EUR 0 of sales, with filings ranging from 2016-02-02 to 2026-04-30, and the modal transaction nature is Attribution.